<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00461357</url>
  </required_header>
  <id_info>
    <org_study_id>NTX-OFO-01</org_study_id>
    <nct_id>NCT00461357</nct_id>
  </id_info>
  <brief_title>Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program</brief_title>
  <acronym>ESP</acronym>
  <official_title>Outcome After Renal Transplantation of a Randomized Prospective Trial in the Eurotransplant Senior Program</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Eurotransplant Senior Program (ESP) started in 1999 with local allocation of kidneys from&#xD;
      deceased donors elder than 65 years to recipients elder than 65 years. The requirements for&#xD;
      immunosuppression in this group of patients are high due to the large amount of&#xD;
      comorbidities.&#xD;
&#xD;
      This prospective randomized trial compared the standard immunosuppressive protocol based on&#xD;
      cyclosporine A (CyA) used at our center within the ESP, to a calcineurin inhibitor-free&#xD;
      protocol based on sirolimus (SRL).&#xD;
&#xD;
      The aim of this study is to investigate the effect of a CNI-free therapy on the function of&#xD;
      elderly kidneys 6 months post transplantation, measured by GFR.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2003</start_date>
  <completion_date type="Anticipated">December 2007</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>48</enrollment>
  <condition>Kidney Function After Transplantation</condition>
  <condition>Outcome After Kidney Transplantation</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Recipients of the Eurotransplant Senior Program&#xD;
&#xD;
          -  negative cytotoxic crossmatch&#xD;
&#xD;
          -  signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  High sensitized recipients (PRA &gt; 40%)&#xD;
&#xD;
          -  Non heart Beating Donor&#xD;
&#xD;
          -  Hyperlipidemia&#xD;
&#xD;
          -  Leucocytopenia (&lt; 3000/mm3)&#xD;
&#xD;
          -  Thrombocytopenia (&lt; 75000/mm3)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ferdinand Muehlbacher, MD Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of Vienna; Department of Transplantation</affiliation>
  </overall_official>
  <verification_date>April 2007</verification_date>
  <study_first_submitted>April 17, 2007</study_first_submitted>
  <study_first_submitted_qc>April 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 18, 2007</study_first_posted>
  <last_update_submitted>April 17, 2007</last_update_submitted>
  <last_update_submitted_qc>April 17, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 18, 2007</last_update_posted>
  <keyword>Old for Old</keyword>
  <keyword>Eurotransplant Senior Program</keyword>
  <keyword>Glomerular Filtration Rate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

